Preclinical Data Demonstrate Sotrovimab Retains Activity Against Key Omicron Mutations, New SARS-CoV-2 Variant

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to Preclinical Data Demonstrate Sotrovimab Retains Activity Against Key Omicron Mutations, New SARS-CoV-2 Variant
(NASDAQ: VIR) Delayed: 10.60 -0.32 (2.93%)
Previous Close $10.92    52 Week High $ 
Open $10.92    52 Week Low $ 
Day High $11.00    P/E N/A 
Day Low $10.44    EPS $ 
Volume 7,017,423